Clinical Trials Directory

Trials / Completed

CompletedNCT01909700

Single Incision Pelvic Floor Mesh Implants

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
157 (actual)
Sponsor
Western Galilee Hospital-Nahariya · Other Government
Sex
Female
Age
30 Years – 90 Years
Healthy volunteers
Accepted

Summary

Objectives: To evaluate whether the use of single incision un-anchored small mesh implants is feasible, safe and effective for women with moderate pelvic organ prolapse. Design: Patients diagnosed with moderate pelvic organ prolapse were enrolled to undergo a single incision un-anchored mesh operation. Follow-up was 4 to 23 months. The outcome measures for this study were the operative safety and post-operative pain, adverse effects and anatomical as well as functional cure. Setting: The operations were performed under general anesthesia according with the reported surgical techniques at university and private hospitals.

Detailed description

Eligibility criteria: female patients with moderate pelvic organ prolapse Outcome measures: intra operative safety and surgical complications, post operative complications and objective as well as subjective cure rates

Conditions

Interventions

TypeNameDescription
DEVICESingle Incision MeshSingle Incision Mesh is implanted for pelvic floor reconstruction

Timeline

Start date
2011-07-01
Primary completion
2011-11-01
Completion
2012-02-01
First posted
2013-07-26
Last updated
2016-05-05

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01909700. Inclusion in this directory is not an endorsement.